Paul J. Mellett Sells 2,412 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) CFO Paul J. Mellett sold 2,412 shares of the firm’s stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $9.63, for a total value of $23,227.56. Following the sale, the chief financial officer now directly owns 93,549 shares in […]

Related Keywords

Canada ,Tennessee ,United States ,Paulj Mellett , ,Enanta Pharmaceuticals Inc ,Quarter For Enanta Pharmaceuticals ,Enanta Pharmaceuticals Stock Performance ,Enanta Pharmaceuticals Company Profile ,Yousif Capital Management ,News Ratings For Enanta Pharmaceuticals Daily ,Hedge Funds Weigh In On Enanta Pharmaceuticals ,Tennessee Treasury Department ,Securities Exchange Commission ,Jefferies Financial Group ,Enanta Pharmaceuticals ,Jpmorgan Chase Co ,Nasdaq ,Royal Bank ,Get Free Report ,Exchange Commission ,Capital Management ,Sigma Investments ,Captrust Financial Advisors ,Financial Advisors ,Financial Group ,Enanta Pharmaceuticals Daily ,Nasdaq Enta ,Enta ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,